Genetic Biomarkers in Chronic Myeloid Leukemia: What Have We Learned So Far?
Chronic Myeloid Leukemia (CML) is a rare malignant proliferative disease of the hematopoietic system, whose molecular hallmark is the Philadelphia chromosome (Ph). The Ph chromosome originates an aberrant fusion gene with abnormal kinase activity, leading to the buildup of reactive oxygen species an...
Main Authors: | Bilal Abdulmawjood, Beatriz Costa, Catarina Roma-Rodrigues, Pedro V. Baptista, Alexandra R. Fernandes |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-11-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/22/12516 |
Similar Items
-
Comparison of microRNA Expression Profile in Chronic Myeloid Leukemia Patients Newly Diagnosed and Treated by Allogeneic Hematopoietic Stem Cell Transplantation
by: Juliana Ravelli Baldassarre Martins, et al.
Published: (2020-09-01) -
Chronic myeloid leukemia (CML): prognostic factors and survival analysis
by: Gisele Wally Braga, et al. -
“Preleukemic or smoldering” chronic myelogenous leukemia (CML):BCR-ABL1 positive: A brief case report
by: John M. Bennett, et al.
Published: (2015-01-01) -
Additional chromosome abnormalities in chronic myeloid leukemia
by: Hui-Hua Hsiao, et al.
Published: (2011-02-01) -
A Case with Neurofibromatosis and Chronic Myeloid Leukemia in Blastic Crisis Treated with Imatinib
by: Gamal Abdul Hamid, et al.
Published: (2014-03-01)